GL1X · GenesisL1 explorer

Research workbench

Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide C-jun NH2-terminal kinase inhibitors

Analyse Discovery of potent, highly selective, and orally bioavailable pyridine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2H96
Type
protein
Length
735 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P45983, Q9UQF2

Structure

x-ray diffraction · 3 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein358—P45983
F, G—protein10—Q9UQF2
B—protein357—P45983

Compared structures

  • 2H96 · Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide C-jun… · the same entry in another collection · chain A against A, TM-score 1.00
  • P45983 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 8 (P45983) · a predicted model of the same protein · chain A against A, TM-score 0.97
  • Q9UQF2 · AlphaFold monomer V2.0 prediction for C-jun-amino-terminal kinase- interacting protein 1… · a predicted model of the same protein · chain F against A, TM-score 0.39

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.